BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22222908)

  • 41. Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.
    Waisser K; Drazková K; Cizmárik J; Kaustová J
    Folia Microbiol (Praha); 2003; 48(1):45-50. PubMed ID: 12744075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimycobacterial activity of a series of pyrazinoic acid esters.
    Cynamon MH; Klemens SP; Chou TS; Gimi RH; Welch JT
    J Med Chem; 1992 Apr; 35(7):1212-5. PubMed ID: 1560435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.
    Krátký M; Stolaříková J; Vinšová J
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28350331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salicylanilide diethyl phosphates as cholinesterases inhibitors.
    Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
    Bioorg Chem; 2015 Feb; 58():48-52. PubMed ID: 25462625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On the relationship between the substitution pattern of thiobenzanilides and their antimycobacterial activity.
    Kunes J; Balsánek V; Pour M; Waisser K; Kaustová J
    Farmaco; 2002 Sep; 57(9):777-82. PubMed ID: 12385530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.
    Klimesová V; Zahajská L; Waisser K; Kaustová J; Möllmann U
    Farmaco; 2004 Apr; 59(4):279-88. PubMed ID: 15081345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis.
    Sahoo SK; Rani B; Gaikwad NB; Ahmad MN; Kaul G; Shukla M; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
    Eur J Med Chem; 2021 Oct; 222():113580. PubMed ID: 34116324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substituted xanthones as antimycobacterial agents, Part 2: Antimycobacterial activity.
    Pickert M; Schaper KJ; Frahm AW
    Arch Pharm (Weinheim); 1998 May; 331(5):193-7. PubMed ID: 9691249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primaquine hybrids as promising antimycobacterial and antimalarial agents.
    Pavić K; Perković I; Pospíšilová Š; Machado M; Fontinha D; Prudêncio M; Jampilek J; Coffey A; Endersen L; Rimac H; Zorc B
    Eur J Med Chem; 2018 Jan; 143():769-779. PubMed ID: 29220797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
    Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salicylanilide and its heterocyclic analogues. A comparative study of their antimicrobial activity.
    Daidone G; Maggio B; Schillaci D
    Pharmazie; 1990 Jun; 45(6):441-2. PubMed ID: 2402534
    [No Abstract]   [Full Text] [Related]  

  • 52. Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
    Paraskevopoulos G; Krátký M; Mandíková J; Trejtnar F; Stolaříková J; Pávek P; Besra G; Vinšová J
    Bioorg Med Chem; 2015 Nov; 23(22):7292-301. PubMed ID: 26526729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
    Cavicchioli M; Leite CQ; Sato DN; Massabni AC
    Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, antimycobacterial activity and in vitro cytotoxicity of 5-chloro-N-phenylpyrazine-2-carboxamides.
    Zitko J; Servusová B; Paterová P; Mandíková J; Kubíček V; Kučera R; Hrabcová V; Kuneš J; Soukup O; Doležal M
    Molecules; 2013 Dec; 18(12):14807-25. PubMed ID: 24317522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of the antimycobacterial activity of 8-hydroxyquinolines.
    Cieslik W; Spaczynska E; Malarz K; Tabak D; Nevin E; O'Mahony J; Coffey A; Mrozek-Wilczkiewicz A; Jampilek J; Musiol R
    Med Chem; 2015; 11(8):771-9. PubMed ID: 26256587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.
    Srivastav NC; Shakya N; Bhavanam S; Agrawal A; Tse C; Desroches N; Kunimoto DY; Kumar R
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1091-4. PubMed ID: 22178557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.
    Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Palát K; Kaustová J; Danse HM; Möllmann U
    Pharmazie; 2003 Feb; 58(2):83-94. PubMed ID: 12641321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids.
    Waisser K; Drazková K; Cizmárik J; Kaustová J
    Folia Microbiol (Praha); 2003; 48(5):585-7. PubMed ID: 14976713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimycobacterial activity of 3'- and 4'-fluorothiobenzanilides.
    Waisser K; Kunes J; Odlerová Z; Roman M; Kubicová L; Horák V
    Pharmazie; 1998 Mar; 53(3):193-5. PubMed ID: 9547521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, Bioactivity Evaluation, and Toxicity Assessment of Novel Salicylanilide Ester Derivatives as Cercaricides against Schistosoma japonicum and Molluscicides against Oncomelania hupensis.
    Wang W; Qin Z; Zhu D; Wei Y; Li S; Duan L
    Antimicrob Agents Chemother; 2016 Jan; 60(1):323-31. PubMed ID: 26503661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.